BridgeMD
New treatment option for Haemodialysis Patients
Official title Pulsatile Flushing Technique in Reducing Blockage of T-CVAD for Haemodialysis Patients
ClinicalTrials.gov ID: NCT07567456
What this study is testing
- What it's testing
- This study investigates the effectiveness of pulsatile flushing techniques in reducing blockage in Tunnelled Central Venous Access Device (T-CVAD) among patients undergoing haemodialysis (HD) treatment at multiple renal centres within the Hospital Authority (HA) in Hong Kong. With limitation in single service protocol for each cluster of renal units, it is designed as a prospective, parallel, cluster non-randomised controlled trial involving 591 patients from 14 renal units.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients undergoing HD treatment with Tunnelled Central Venous Access Device (T-CVAD) in the above collaborators under the Hospital Authority
- Able to understand spoken and written Chinese or English
You likely can't join if
- Patients with Non-Tunnelled Central Venous Access Device (NT-CVAD)
- Temporary dysfunction (e.g., kicking of the catheter) resolved with repositioning
- Confirmed case of fibrin sheath occlusion which can only be resolved through surgical intervention
- Non-thrombotic occlusion due to mechanical causes (e.g., catheter malposition)
- Patient declined or incompetent to provide written informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Kowloon, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kowloon, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.